Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Rev Med Interne ; 43(7): 402-405, 2022 Jul.
Article in English | MEDLINE | ID: covidwho-1886066

ABSTRACT

INTRODUCTION: Recreational use of nitrous oxide (N2O) is increasing in Western countries, including France. During the COVID-19 pandemic, some authors warned that recreational N2O use could increase further as the supply of illicit drugs was impacted by various containment measures. METHODS: We retrospectively analyzed N2O exposures reported to the Paris Poison Control Center (France) from 2010/01/01 to 2021/04/15. The Poison Severity Score was used to grade severity. RESULTS: During the study period, 93 cases of N2O recreational exposures were reported (male/female ratio: 1.1; median age: 20.9 years range: [14.8-49.0]). The first case was reported in 2012, 84/93 (90%) and 65/93 (70%) were reported since 2019 and March 17th 2020 (first lockdown in France) respectively. Most of the patients were symptomatic (88/93; 95%) and developed neurological symptoms (78/93; 84%). Among the fourteen patients who developed moderate to severe symptoms, eleven were reported after March 2020. CONCLUSION: Despite a marked increase in recreational N2O exposures during the COVID-19 pandemic, the exact impact of COVID-19 on this increase remains to be determined as it was observed from 2019.


Subject(s)
COVID-19 , Substance-Related Disorders , Adult , COVID-19/epidemiology , Communicable Disease Control , Female , France/epidemiology , Humans , Male , Nitrous Oxide/adverse effects , Pandemics , Paris/epidemiology , Retrospective Studies , Substance-Related Disorders/epidemiology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL